Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

787
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
787
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

1.7K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.7K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

1.2K
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
1.2K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Working Well in a Dynamic Nursing Career: A Critical Incident Technique Study of Nurses' Actions for a Sustainable Working Life.

Journal of nursing management·2026
Same author

Everyday life experiences of family members of individuals with restless legs syndrome: a qualitative interview study.

Journal of research in nursing : JRN·2026
Same author

Family Members' Experiences of Weaning From Mechanical Ventilation in Intensive Care: A Hermeneutic Phenomenological Study.

Nursing open·2026
Same author

Experiences of sleep problems, subsequent daytime consequences, and self-care activities used to improve sleep among patients with restless legs syndrome: a qualitative content analysis.

Journal of research in nursing : JRN·2025
Same author

Navigating the Border - How Swedish Physicians Approach Palliative Care Referrals in Oncology.

Cancer control : journal of the Moffitt Cancer Center·2025
Same author

Validation of the eHealth Literacy Scale Instrument in a Restless Legs Syndrome Population: Classical Test Theory and Rasch Analysis Study.

Journal of medical Internet research·2025

Related Experiment Video

Updated: Apr 30, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.4K

Sexual dysfunction in heart failure patients.

Tiny Jaarsma1, Bengt Fridlund, Jan Mårtensson

  • 1Department of Social and Welfare Studies, Faculty of Health Sciences, University of Linköping, 58183, Linköping, Sweden, tiny.jaarsma@liu.se.

Current Heart Failure Reports
|May 8, 2014
PubMed
Summary
This summary is machine-generated.

Sexual dysfunction is common in heart failure (HF) patients, affecting both men and women. This review offers clinicians guidance on assessing and treating sexual problems in HF patients.

More Related Videos

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

6.8K

Related Experiment Videos

Last Updated: Apr 30, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.4K
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

6.8K

Area of Science:

  • Cardiology
  • Sexual Medicine
  • Psychology

Background:

  • Sexual dysfunction significantly impacts the quality of life for heart failure (HF) patients.
  • Current healthcare often inadequately addresses and treats sexual problems in HF populations.
  • Multiple factors contribute to sexual dysfunction, including physical, psychological, and medication-related issues.

Purpose of the Study:

  • To provide clinicians with a comprehensive review of sexual dysfunction in heart failure (HF).
  • To outline practical steps for assessing and managing sexual problems in HF patients.

Main Methods:

  • Literature review summarizing current knowledge on sexual dysfunction in HF.
  • Identification of contributing factors and recommended treatment strategies.

Main Results:

  • Sexual problems are prevalent in both male and female HF patients.
  • Key contributing factors include activity intolerance, psychological distress, physiological changes, cardiac medications, lifestyle, and comorbidities.
  • Effective management involves comprehensive assessment and addressing underlying conditions.

Conclusions:

  • Clinicians should proactively assess and manage sexual dysfunction in HF patients.
  • Treatment strategies include optimizing HF and comorbidity management, addressing psychosocial issues, managing risk factors, and considering pharmacotherapy like PDE-5 inhibitors.